Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |